Takeda Oncology
Julian Graham has extensive experience in sales and account management, particularly in the oncology sector. Currently serving as an Account Manager for Takeda Oncology since May 2016, Julian held a secondment as Divisional Sales Director from 2020 to 2021, overseeing financial performance, talent development, and compliance within the Oncology Business Unit. Prior to this role, Julian worked as a Senior Key Account Specialist at Shire and held positions at Novartis and Innovex, focusing on driving sales in various therapeutic areas. Julian also has experience in commercial management and financial consulting, demonstrating a strong background in client relationship building and revenue generation. Academic credentials include a Bachelor of Science in Business/Sports Studies from the University of Surrey and The University of Sheffield.
This person is not in any teams
This person is not in any offices
Takeda Oncology
21 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.